Przejdź do zawartości
Merck

The end of the beginning: circulating tumor cells as a biomarker in castration-resistant prostate cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2014-03-13)
Terence W Friedlander, Lawrence Fong
MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
Docetaxel, purum, ≥97.0% (HPLC)
Anhydrous Docetaxel, European Pharmacopoeia (EP) Reference Standard